Interpretation and Diagnostic Use of Ceruloplasmin in Wilson Disease

Diagnostic Accuracy of Low Ceruloplasmin

• In patients with low ceruloplasmin, only 5.9 % actually have Wilson disease, giving a positive predictive value of ≈ 6 % when used as a screening test in liver disease cohorts. [@1]
• Extremely low ceruloplasmin concentrations (< 50 mg/L or < 5 mg/dL) constitute strong evidence for Wilson disease and should trigger immediate comprehensive evaluation. [@2]
• In confirmed Wilson disease, ceruloplasmin is typically < 0.1 g/L (10 mg/dL) and contributes 2 points to the Leipzig diagnostic scoring system. [@1][@3]
• The combination of ceruloplasmin < 0.1 g/L and Kayser‑Fleischer rings is usually sufficient to establish a definitive diagnosis of Wilson disease. [@4]

Limitations and Sources of False‑Negative Results

* 15‑36 % of children with Wilson disease have ceruloplasmin values within the normal laboratory range, leading to false‑negative results. [@3]

• Approximately 50 % of patients with active hepatic Wilson disease exhibit low‑normal ceruloplasmin levels, further reducing diagnostic sensitivity. [@1][@3]
• Ceruloplasmin is an acute‑phase reactant; acute inflammation can raise its concentration to normal levels, masking disease. [@1][@5]
• In acute liver failure, both ceruloplasmin and total serum copper may be misleading because massive hepatic copper release can elevate serum copper despite low ceruloplasmin. [@1][@2]

Causes of False‑Positive Low Ceruloplasmin

• About 20 % of heterozygous ATP7B carriers display decreased ceruloplasmin without having Wilson disease. [@1][@2]
• Severe end‑stage liver disease of any etiology can lower ceruloplasmin concentrations. [@1][@3]
• Marked renal or enteric protein loss leads to reduced ceruloplasmin levels. [@1]
• Malabsorption syndromes, including celiac disease, are associated with low ceruloplasmin. [@4]
• Aceruloplasminemia (genetic ceruloplasmin deficiency without copper overload) produces low ceruloplasmin values. [@1][@3]
• Autoimmune hepatitis may also result in reduced ceruloplasmin. [@4]

Recommended Diagnostic Algorithm (Leipzig Scoring System)

The Leipzig scoring system is advised over reliance on ceruloplasmin alone. [@1][@5]

Score interpretation:
 ≥ 4 points → Wilson disease diagnosed. [@3][@5]
 3 points → Diagnosis possible; additional testing required. [@3][@5]
* ≤ 2 points → Wilson disease unlikely. [@3][@5]

Essential Complementary Testing When Ceruloplasmin Is Low

• Perform slit‑lamp examination for Kayser‑Fleischer rings; absent in up to 50 % of hepatic presentations. [@3][@5]
• Measure 24‑hour urinary copper excretion; values > 1.6 µmol/24 h are typical for Wilson disease (lower pediatric cutoff ≈ 0.64 µmol/24 h). [@1]
• Calculate non‑ceruloplasmin‑bound (“free”) copper: total serum copper – [ceruloplasmin × 3.15]; values > 200 µg/L suggest untreated Wilson disease. [@1]
• Quantify hepatic copper via liver biopsy when feasible; > 4 µmol/g dry weight is diagnostic. [@5]
• Conduct ATP7B genetic testing, especially for asymptomatic siblings or when biochemical results are inconclusive. [@2]

Clinical Pitfalls

• Do not exclude Wilson disease solely on the basis of a normal ceruloplasmin, particularly in pediatric patients with hepatic disease. [@3]
• Consider Wilson disease in any individual aged 3‑45 years presenting with unexplained liver abnormalities, neuropsychiatric symptoms, or hemolytic anemia. [@2]
• Immunologic assays may overestimate ceruloplasmin by detecting both apo‑ and holoceruloplasmin; enzymatic oxidase activity assays are more specific but less widely available. [@1][@3]
• In acute liver failure, both ceruloplasmin and total serum copper can be misleading; serum copper may be markedly elevated due to sudden hepatic copper release. [@1][@2]

Diagnostic Approach for Wilson Disease

Key Diagnostic Considerations

• The European Association for the Study of the Liver recommends that a combination of tests be used for the diagnosis of Wilson disease, as no single test is sufficient for diagnosis, with the Leipzig scoring system being the most validated diagnostic approach 1, 2
• Low serum ceruloplasmin (<50 mg/L or <5 mg/dL) should be considered strong evidence for Wilson disease, but modestly subnormal levels require further evaluation, according to the American Association for the Study of Liver Diseases 3
• Normal serum ceruloplasmin does not exclude Wilson disease, as 15-36% of patients (especially those with hepatic manifestations) may have normal levels, as noted by the European Association for the Study of the Liver 4
• Basal 24-hour urinary copper excretion >1.6 μmol (>100 μg) is typical in symptomatic patients, as indicated by the European Association for the Study of the Liver 5
• The presence of Kayser-Fleischer rings by slit-lamp examination is highly suggestive of Wilson disease, according to the American Association for the Study of Liver Diseases 4
• A score of 4 or more on the Leipzig Diagnostic Scoring System establishes the diagnosis, as recommended by the European Association for the Study of the Liver 4, 2
• Hepatic copper content >4 μmol/g dry weight provides critical diagnostic information, as noted by the European Association for the Study of the Liver 5
• Non-ceruloplasmin bound copper (calculated as total serum copper minus ceruloplasmin-bound copper) is typically elevated above 200 μg/L in untreated patients, according to the European Association for the Study of the Liver 6, 7
• Genetic testing, such as mutation analysis of the ATP7B gene, can confirm the diagnosis, as recommended by the European Association for the Study of the Liver 5

Diagnostic Scoring System

Common Pitfalls and Caveats

• Ceruloplasmin can be elevated by acute inflammation, pregnancy, or estrogen therapy, as noted by the European Association for the Study of the Liver 6
• Approximately 20% of heterozygotes for Wilson disease may have decreased ceruloplasmin levels, according to the European Association for the Study of the Liver 4
• Non-ceruloplasmin bound copper may be elevated in acute liver failure of any etiology, chronic cholestasis, and copper intoxication, as indicated by the European Association for the Study of the Liver 6